Deamidated Gliadin Peptides as Targets for Celiac Disease-Specific Antibodies

Advances in Clinical Chemistry

Volumn 44, Issue , 2007, Pages 35-63

  Mothes, Thomas ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AUTOANTIBODY; EPITOPE; GLIADIN; PEPTIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANTIBODY SPECIFICITY; BLOOD; CELIAC DISEASE; CHEMISTRY; ENZYME SPECIFICITY; HUMAN; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ANTIBODIES; ANTIBODY SPECIFICITY; AUTOANTIBODIES; CELIAC DISEASE; EPITOPES; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; GLIADIN; HUMANS; PEPTIDES; SUBSTRATE SPECIFICITY; TRANSGLUTAMINASES;

EID: 34347403261     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2423(07)44002-1     Document Type: Review

References (192)

1. Dieterich W., Ehnis T., Bauer M., Donner P., Volta U., Riecken E., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3 (1997) 797-801
2. Accomando S., and Cataldo F. The global village of celiac disease. Dig Liver Dis 36 (2004) 492-498
3. Janatuinen E., Pikkarainen P., Kemppainen T., Kosma V., Jarvinen R., Uusitupa M., et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 333 (1995) 1033-1037
4. Srinivasan U., Leonard N., Jones E., Kasarda D., Weir D., O'Farrelly C., et al. Absence of oats toxicity in adult coeliac disease. Br Med J 313 (1996) 1300-1301
5. Lundin K., Nilsen E., Scott H., Loberg E., Gjoen A., Bratlie J., et al. Oats induced villous atrophy in coeliac disease. Gut 52 (2003) 1649-1652
6. Arentz-Hansen H., Fleckenstein B., Molberg O., Scott H., Koning F., Jung G., et al. The molecular basis for oat intolerance in patients with celiac disease. PLoS Med 1 (2004) 84-92
7. Osborne T. The Vegetable Proteins. 2nd ed. (1924), Longmans, Green and Co., London
8. Wieser H. The precipitating factor in coeliac disease. Baillieres Clin Gastroenterol 9 (1995) 191-207
9. Stern M., Ciclitira P., van Eckert R., Feighery C., Janssen F., Mendez E., et al. Analysis and clinical effects of gluten in coeliac disease. Eur J Gastroenterol Hepatol 13 (2001) 741-747
10. Codex Alimentarius Home Page. 25th Session of the Codex Committee on Nutrition and Foods for Special Dietary Uses (ALINORM 04/27/26), page 4: Appendix III. Draft revised standard for gluten-free foods Bonn, Germany, 3-7 November 2003. http://www.codexalimentarius.net/web/codex/codex27_en.htm (Accessed February 2006)
11. Shewry P., Field J., and Tatham A. The structure of cereal storage proteins. In: Morton, and I. (Ed). Cereals in a European Context (1987), Ellis Harwood, Chichester 421-437
12. Shewry P., Napier J., and Tatham A. Seed storage proteins: Structures and biosynthesis. Plant Cell 7 (1995) 945-956
13. Shewry P., and Tatham A. The prolamin storage proteins of cereal seeds: Structure and evolution. Biochem J 267 (1990) 1-12
14. Shewry P., and Halford N. Cereal seed storage proteins: Structures, properties and role in grain utilization. J Exp Bot 53 (2002) 947-958
15. van de Wal Y., Kooy Y., van Veelen P., Vader W., August S., Drijfhout J., et al. Glutenin is involved in the gluten-driven mucosal T cell response. Eur J Immunol 29 (1999) 3133-3139
16. Vader W., Kooy Y., Van Veelen P., De Ru A., Harris D., Benckhuijsen W., et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 122 (2002) 1729-1737
17. Molberg O., Solheim Flaete N., Jensen T., Lundin K., Arentz-Hansen H., Anderson O., et al. Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease. Gastroenterology 125 (2003) 337-344
18. U.S. National Center for Biotechnology Information Home Page. http://www.ncbi.nlm.nih.gov/ (Accessed January 2006)
19. 13 C-n.m.r. study of C hordein. Biochem J 232 (1985) 617-620
20. Tatham A., Marsh M., Wieser H., and Shewry P. Conformational studies of peptides corresponding to the coeliac-activating regions of wheat alpha-gliadin. Biochem J 270 (1990) 313-318
21. Tatham A., and Shewry P. The S-poor prolamins of wheat, barley and rye. J Cereal Sci 22 (1995) 1-16
22. IUB/IUPAC (International Union of Biochemistry/International Union of Pure and Applied Chemistry). http://www.chem.qmul.ac.uk/iupac/AminoAcid/A2021.html (Accessed march 2006)
23. Kahlenberg F., Sanchez D., Lachmann I., Tuckova L., Tlaskalova H., Méndez E., et al. Monoclonal antibody R5 for detection of putatively coeliac-toxic gliadin peptides. Eur Food Res Technol 222 (2006) 78-82
24. Parrot I., Huang P., and Khosla C. Circular dichroism and nuclear magnetic resonance spectroscopic analysis of immunogenic gluten peptides and their analogs. J Biol Chem 277 (2002) 45572-45578
25. Chartrand L., and Seidman E. Celiac disease is a lifelong disorder. Clin Invest Med 19 (1996) 357-361
26. Fasano A. Clinical presentation of celiac disease in the pediatric population. Gastroenterology 128 4 Suppl 1 (2005) S68-S73
27. Schmitz J. Is celiac disease a lifelong disorder?. Clin Invest Med 19 (1996) 352-356
28. Limbach A., Hoepffner W., Tannapfel A., Müller D., Mothes T., and Richter T. Long-term study of patients with coeliac disease in childhood and adolescence: Latent or transient coeliac disease?. Klin Padiatr 215 (2003) 76-81
29. Davidson A., and Bridges M. Coeliac disease: An analysis of aetiological possibilities and re-evaluation of the enzymopathic hypothesis. Med Hypotheses 26 (1988) 155-160
30. Cornell H. Amino acid composition of peptides remaining after in vitro digestion of a gliadin sub-fraction with duodenal mucosa from patients with coeliac disease. Clin Chim Acta 176 (1988) 279-289
31. Cornell H. Mucosal digestion studies of whole gliadin fractions in coeliac disease. Ann Clin Biochem 27 (1990) 44-49
32. Cornell H. Partial in vitro digestion of active gliadin-related peptides in celiac disease. J Protein Chem 17 (1998) 739-744
33. Cornell H., and Rivett D. In vitro mucosal digestion of synthetic gliadin-derived peptides in celiac disease. J Protein Chem 14 (1995) 335-339
34. Shan L., Molberg O., Parrot I., Hausch F., Filiz F., Gray G., et al. Structural basis for gluten intolerance in celiac sprue. Science 297 (2002) 2275-2279
35. Hausch F., Shan L., Santiago N., Gray G., and Khosla C. Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol Gastrointest Liver Physiol 283 (2002) G996-G1003
36. Shan L., Qiao S., Arentz-Hansen H., Molberg O., Gray G., Sollid L., et al. Identification and analysis of multivalent proteolytically resistant peptides from gluten: Implications for celiac sprue. J Proteome Res 4 (2005) 1732-1741
37. Piper J., Gray G., and Khosla C. Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo. J Pharmacol Exp Ther 311 (2004) 213-219
38. Matysiak-Budnik T., Candalh C., Cellier C., Dugave C., Namane A., Vidal-Martinez T., et al. Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease. Gastroenterology 129 (2005) 786-796
39. Pyle G., Paaso B., Anderson B., Allen D., Marti T., Li Q., et al. Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue. Clin Gastroenterol Hepatol 3 (2005) 687-694
40. Marti T., Molberg O., Li Q., Gray G., Khosla C., and Sollid L. Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: Chemical and immunological characterization. J Pharmacol Exp Ther 312 (2005) 19-26
41. Cornell H., Macrae F., Melny J., Pizzey C., Cook F., Mason S., et al. Enzyme therapy for management of coeliac disease. Scand J Gastroenterol 40 (2005) 1304-1312
42. Stern M., and Gellermann B. Food proteins and maturation of small intestinal microvillus membranes (MVM). I. Binding characteristics of cows milk proteins and concanavalin A to MVM from newbom and adult rats. J Pediatr Gastroenterol Nutr 7 (1988) 115-121
43. Stern M., Gellermann B., Belitz H., and Wieser H. Food proteins and maturation of small intestinal rnicrovillus membranes (MVM). II. Binding of gliadin hydrolysate fractions and of the gliadin peptide B3142. J Pediatr Gastroenterol Nutr 7 (1988) 122-127
44. Stern M., Gellermann B., and Wieser H. Food proteins and maturation of smal1 intestinal microvillus membranes (MVM). III. Food protein binding and MVM proteins in rats fromnewbom to young adult age. J Pediatr Gastroenterol Nutr 11 (1990) 389-394
45. Bolte G., Osman A., Mothes T., and Stern M. Peptic-tryptic digests of gliadin: Contaminating trypsin but not pepsin interferes with gastrointestinal protein binding characteristics. Clin Chim Acta 247 (1996) 59-70
46. Bolte G., Seilmeier W., Wieser H., Holm K., Beuermann K., Newport B., et al. Enhanced peptide-binding capacities of small intestinal brush border membranes in celiac disease. Pediatr Res 46 (1999) 666-670
47. Köttgen E., Volk B., Kluge F., and Gerok W. Gluten, a lectin with oligomannosyl specificity and the causative agent of gluten-sensitive enteropathy. Biochem Biophys Res Commun 109 (1982) 168-173
48. Farré Castany M., Kocna P., and Tlaskalova-Hogenova H. Binding of gliadin to Iymphoblastoid, myeloid, and epithelial cell lines. Folia Microbiol 40 (1995) 431-435
49. Bendix U., Lentz S., Rothschild M., Lehmann I., Osman A., and Mothes T. Effect of γ-interferon on binding of gliadin and other food peptides to the human intestinal cell line HT-29. Clin Chim Acta 261 (1997) 69-80
50. Co1yer J., Kumar P., Waldron N., Clark M., and Farthing M. G1iadin binding to rat and human enterocytes. Clin Sci 72 (1987) 593-598
51. Pittschieler K., Ladinser B., and Petell J. Reactivity of gliadins and lectins with celiac intestinal mucosa. Pediatr Res 36 (1994) 635-641
52. Friis S., Dabelsteen E., Sjöström H., Norén O., and Jarnum S. Gliadin uptake in human enterocytes. Differences between coeliac patients in remission and control individuals. Gut 33 (1992) 1487-1492
53. Zimmer K., Poremba C., Weber P., Ciclitira P., and Harms E. Translocation of gliadin into HLA-DR antigen containing lysosomes in coeliac disease enterocytes. Gut 36 (1995) 703-709
54. Zimmer K., Naim H., Weber P., Ellis H., and Ciclitira P. Targeting of gliadin peptides, CD8, alpha/beta-TCR, and gamma/delta-TCR to Golgi complexes and vacuoles within celiac disease enterocytes. FASEB J 12 (1998) 1349-1357
55. Fasano A., Not T., Wang W., Uzzau S., Berti I., Tommasini A., et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 355 (2000) 1518-1519
56. Clemente M., De Virgiliis S., Kang J., Macatagney R., Musu M., Di Pierro M., et al. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 52 (2003) 218-223
57. Weiser M., and Douglas A. An alternative mechanism for gluten toxicity in coeliac disease. Lancet 13 (1976) 567-569
58. Mothes T., Bendix U., Pfannschmidt C., and Lehmann I. Effect of gliadin and other food peptides on expression of MHC-class II molecules by HT-29 cells. Gut 36 (1995) 548-552
59. Auricchio S., De Ritis G., De Vincenzi M., Mancini E., Minetti M., Sapora O., et al. Agglutinating activity of gliadin-derived peptides from bread wheat: Implications for coeliac disease pathogenesis. Biochem Biophys Res Commun 121 (1984) 428-433
60. Farré M., Tlaskalova H., Nguyen H., Kocna P., Tuckova L., Krchnak V., et al. Interaction of natural and synthetic peptides derived from gliadin with different cell lines. Adv Exp Med Biol 371B (1995) 1371-1373
61. De Vincenzi M., Luchetti R., Giovannini C., Pogna N., Saponaro C., Galterio G., et al. In vitro toxicity testing of alcohol-soluble proteins from diploid wheat Triticum monococcum in celiac disease. J Biochem Toxicol 11 (1996) 313-318
62. Jelinkova L., Tuckova L., Cinova J., Flegelova Z., and Tlaskalova-Hogenova H. Gliadin stimulates human monocytes to production of IL-8 and TNF-alpha through a mechanism involving NF-kappaB. FEBS Lett 571 (2004) 81-85
63. Gianfrani C., Auricchio S., and Troncone R. Adaptive and innate immune responses in celiac disease. Immunol Lett 99 (2005) 141-145
64. Londei M., Ciacci C., Ricciardelli I., Vacca L., Quaratino S., and Maiuri L. Gliadin as a stimulator of innate responses in celiac disease. Mol Immunol 42 (2005) 913-918
65. Meresse B., Chen Z., Ciszewski C., Tretiakova M., Bhagat G., Krausz T., et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21 (2004) 357-366
66. Sollid L., and Jabri B. Is celiac disease an autoimmune disorder?. Curr Opin Immunol 17 (2005) 595-600
67. Nilsen E., Lundin K., Krajci P., Scott H., Sollid L., and Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 37 (1995) 766-776
68. Nilsen E., Jahnsen F., Lundin K., Johansen F., Fausa O., Sollid L., et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 115 (1998) 551-563
69. Greco L., Romino R., Coto I., Di Cosmo N., Percopo S., Maglio M., et al. The first large population based twin study of coeliac disease. Gut 50 (2002) 624-628
70. Clot F., Gianfrani C., Babron M., Bouguerra F., Southwood S., Kagnoff M., et al. HLA-DR53 molecules are associated with susceptibility to celiac disease and selectively bind gliadin-derived peptides. Immunogenetics 49 (1999) 800-807
71. Louka A., and Sollid L. HLA in coeliac disease: Unravelling the complex genetics of a complex disorder. Tissue Antigens 61 (2003) 105-117
72. Johansen B., Gjertsen H., Vartdal F., Buus S., Thorsby E., Lundin K., et al. Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays. Clin Immunol Immunopathol 79 (1996) 288-293
73. van de Wal Y., Kooy Y., Drijfhout J., Amons R., and Koning F. Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule. Immunogenetics 44 (1996) 246-253
74. Vartdal F., Johansen B., Friede T., Thorpe C., Stevanovic S., Eriksen J., et al. The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. Eur J Immunol 26 (1996) 2764-2772
75. Johansen B., Vartdal F., Eriksen J., Thorsby E., and LM S. Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol 8 (1996) 177-182
76. Godkin A., Friede T., Davenport M., Stevanovic S., Willis A., Jewell D., et al. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). Int Immunol 9 (1997) 905-911
77. Uhlig H., Osman A., Tanev I., Viehweg J., and Mothes T. Role of tissue transglutaminase in gliadin binding to reticular extracellular matrix and relation to coeliac disease autoantibodies. Autoimmunity 28 (1998) 185-195
78. Sollid L., Molberg O., McAdam S., and Lundin K. Autoantibodies in coeliac disease: Tissue transglutaminase-guilt by association?. Gut 41 (1997) 851-852
79. van de Wal Y., Kooy Y., van Veelen P., Pena S., Mearin L., Papadopoulos G., et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 161 (1998) 1585-1588
80. Molberg O., Mcadam S., Korner R., Quarsten H., Kristiansen C., Madsen L., et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by Gut-derived T cells in celiac disease. Nat Med 4 (1998) 713-717 Erratum in:
81. Molberg O., Mcadam S., Korner R., Quarsten H., Kristiansen C., Madsen L., et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by Gut-derived T cells in celiac disease. Nat Med 4 (1998) 974
82. Quarsten H., Molberg O., Fugger L., McAdam S., and Sollid L. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope. Eur J Immunol 29 (1999) 2506-2514
83. Arentz-Hansen H., Korner R., Molberg O., Quarsten H., Vader W., Kooy Y., et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 191 (2000) 603-612
84. Skovbjerg H., Koch C., Anthonsen D., and Sjostrom H. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease. Biochim Biophys Acta 1690 (2004) 220-230
85. Mazzarella G., Maglio M., Paparo F., Nardone G., Stefanile R., Greco L., et al. An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients. Gut 52 (2003) 57-62
86. Senger S., Maurano F., Mazzeo M., Gaita M., Fierro O., Greco C., et al. Identification of immunodominant epitopes of alpha-gliadin in HLA-DQ8 transgenic mice following oral immunization. J Immunol 175 (2005) 8087-8095
87. Walker-Smith J., Guandalini S., Schmitz J., Shmerling D., and Visakorpi J. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 65 (1990) 909-911
88. Troncone R., Bhatnagar S., Butzner D., Cameron D., Hill I., Hoffenberg E., et al. European Society for Paediatric Gastroenterology, Hepatology Nutrition: Celiac disease and other immunologically mediated disorders of the gastrointestinal tract: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 39 Suppl 2 (2004) S601-S610
89. Hill I., Dirks M., Liptak G., Colletti R., Fasano A., Guandalini S., et al. Guideline for the diagnosis and treatment of celiac disease in children: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 40 (2005) 1-19
90. Holtmeier W., Henker J., Riecken E., and Zimmer K. Definitions of celiac disease-statement of an expert group from the German Society for Celiac Disease. Z Gastroenterol 43 (2005) 751-754
91. Marsh M. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterol 102 (1992) 330-354
92. Berger E., Bürgin-Wolff A., and Freudenberg E. Diagnostic value of the demonstration of gliadin antibodies in celiac disease. Klin Wochenschr 42 (1964) 788-790
93. Kull K., Uibo O., Salupere R., Metskula K., and Uibo R. High frequency of antigliadin antibodies and absence of antireticulin and antiendomysium antibodies in patients with ulcerative colitis. J Gastroenterol 34 (1999) 61-65
94. Ots M., Uibo O., Metskula K., Uibo R., and Salupere V. IgA-antigliadin antibodies in patients with IgA nephropathy: The secondary phenomenon?. Am J Nephrol 19 (1999) 453-458
95. Zuin G., Fontana M., Morelli A., Sangaletti O., Marchisio P., and Principi N. Antigliadin antibodies in HIV-infected children. Pediatr AIDS HIV Infect 7 (1996) 409-412
96. Paimela L., Kurki P., Leirisalo-Repo M., and Piirainen H. Gliadin immune reactivity in patients with rheumatoid arthritis. Clin Exp Rheumatol 13 (1995) 603-607
97. Bürk K., Bosch S., Muller C., Melms A., Zühlke C., Stern M., et al. Sporadic cerebellar ataxia associated with gluten sensitivity. Brain 124 (2001) 1013-1019
98. Schrödl D., Kahlenberg F., Zimmer K., Hermann W., Kühn H., and Mothes T. Intrathecal synthesis of autoantibodies against tissue transglutaminase. J Autoimmun 22 (2004) 335-340
99. Serratrice J., Attarian S., Disdier P., Weiller P., and Serratrice G. Neuromuscular diseases associated with antigliadin antibodies. A contentious concept. Acta Myol 23 (2004) 146-150
100. Anheim M., Degos B., Echaniz-Laguna A., Fleury M., Grucker M., and Tranchant C. Ataxia associated with gluten sensitivity, myth or reality?. Rev Neurol (Paris) 162 (2006) 214-221
101. Seah P., Fry L., Hoffbrand A., and Holborow E. Tissue antibodies in dermatitis herpetiformis and adult coeliac disease. Lancet 1 (1971) 834-836
102. Alp M., and Wright R. Autoantibodies to reticulin in patients with idiopathic steatorrhoea, coeliac disease, and Crohn's disease, and their relation to immunoglobulins and dietary antibodies. Lancet 2 (1971) 682-685
103. Seah P., Fry L., Rossiter M., Hoffbrand A., and Holborow E. Anti-reticulin antibodies in childhood coeliac disease. Lancet 2 (1971) 681-682
104. Wright R., and Alp M. Autoantibodies to reticulin in patients with various gastrointestinal diseases and their relationship to immunoglobulins and dietary antibodies. Gut 12 (1971) 858-859
105. Chorzelski T., Sulej J., Tchorzewska H., Jablonska S., Beutner E., and Kumar V. IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann NY Acad Sci 420 (1983) 325-334
106. Chorzelski T., Beutner E., Sulej J., Tchorzewska H., Jablonska S., Kumar V., et al. IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease. Br J Dermatol 111 (1984) 395-402
107. Karpati S., Bürgin-Wolff A., Krieg T., Meurer M., Stolz W., and Braun-Falco O. Binding to human jejunum of serum IgA antibody from children with coeliac disease. Lancet 336 (1990) 1335-1338
108. Ladinser B., Rossipal E., and Pittschieler K. Endomysium antibodies in coeliac disease: An improved method. Gut 35 (1994) 776-778
109. Dieterich W., Laag E., Schopper H., Volta U., Ferguson A., Gillett H., et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 115 (1998) 1317-1321
110. Sulkanen S., Halttunen T., Laurila K., Kolho K., Korponay-Szabo I., Sarnesto A., et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115 (1998) 1322-1328
111. Amin M., Eckhardt T., Kapitza S., Fleckenstein B., Jung G., Seissler J., et al. Correlation between tissue transglutaminase antibodies and endomysium antibodies as diagnostic markers of coeliac disease. Clin Chim Acta 82 (1999) 219-225
112. Sardy M., Odenthal U., Karpati S., Paulsson M., and Smyth N. Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. Clin Chem 45 (1999) 2142-2149
113. Seissler J., Boms S., Wohlrab U., Morgenthaler N., Mothes T., Boehm B., et al. Antibodies to human recombinant tissue transglutaminase measured by radioligand assay: Evidence for high diagnostic sensitivity for celiac disease. Horm Metab Res 31 (1999) 375-379
114. Sblattero D., Berti I., Trevisiol C., Marzari R., Tommasini A., Bradbury A., et al. Human recombinant tissue transglutaminase ELISA: An innovative diagnostic assay for celiac disease. Am J Gastroenterol 95 (2000) 1253-1257
115. Bonamico M., Tiberti C., Picarelli A., Mariani P., Rossi D., Cipolletta E., et al. Radioimmunoassay to detect antitransglutaminase autoantibodies is the most sensitive and specific screening method for celiac disease. Am J Gastroenterol 96 (2001) 1536-1540
116. Osman A., Richter T., Stern M., Conrad K., Henker J., Brandsch C., et al. Production of recombinant human tissue transglutaminase using baculovirus expression system and its application for serologic diagnosis of coeliac disease. Eur J Gastroenterol Hepatol 14 (2002) 1217-1223
117. Clemente M., Musu M., Frau F., Lucia C., and De Virgiliis S. Antitissue transglutaminase antibodies outside celiac disease. J Pediatr Gastroenterol Nutr 34 (2002) 31-34
118. Stern M. Working Group on Serologic Screening for Celiac Disease: Comparative evaluation of serologic tests for celiac disease: A European initiative toward standardization. J Pediatr Gastroenterol Nutr 3 (2000) 513-519
119. Hill I. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations?. Gastroenterol 128 4 Suppl 1 (2005) S25-S32
120. van Meensel B., Hiele M., Hoffman I., Vermeire S., Rutgeerts P., Geboes K., et al. Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease. Clin Chem 50 (2004) 2125-2135
121. Rostom A., Dube C., Cranney A., Saloojee N., Sy R., Garritty C., et al. The diagnostic accuracy of serologic tests for celiac disease: A systematic review. Gastroenterol 128 4 Suppl 1 (2005) S38-S46
122. Zintzaras E., and Germenis A. Performance of antibodies against tissue transglutaminase for the diagnosis of celiac disease: Meta-analysis. Clin Vaccine Immunol 13 (2006) 187-192
123. Gillett H., and Freeman H. Comparison of IgA endomysium antibody and IgA tissue transglutaminase antibody in celiac disease. Can J Gastroenterol 14 (2000) 668-671
124. Basso D., Gallo N., Guariso G., Pittoni M., Piva M., and Plebani M. Role of anti-transglutaminase (anti-tTG), anti-gliadin, and anti-endomysium serum antibodies in diagnosing celiac disease: A comparison of four different commercial kits for anti-tTG determination. J Clin Lab Anal 15 (2001) 112-115
125. Salmaso C., Ocmant A., Pesce G., Altrinetti V., Montagna P., Descalzi D., et al. Comparison of ELISA for tissue transglutaminase autoantibodies with antiendomysium antibodies in pediatric and adult patients with celiac disease. Allergy 56 (2001) 544-547
126. Jaskowski T., Schroder C., Martins T., Litwin C., and Hill H. IgA antibodies against endomysium and transglutaminase: A comparison of methods. J Clin Lab Anal 15 (2001) 108-111
127. Shamir R., Eliakim R., Lahat N., Sobel E., and Lerner A. ELISA of anti-endomysial antibodies in the diagnosis of celiac disease: Comparison with immunofluorescence assay of anti-endomysial antibodies and tissue transglutaminase antibodies. Isr Med Assoc J 4 (2002) 594-596
128. Schwertz E., Kahlenberg F., Sack U., Richter T., Stern M., Conrad K., et al. Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin Chem 50 (2004) 2370-2375
129. Scoglio R., Di Pasquale G., Pagano G., Lucanto M., Magazzu G., and Sferlazzas C. Is intestinal biopsy always needed for diagnosis of celiac disease?. Am J Gastroenterol 98 (2003) 1325-1331
130. Barker C., Mitton C., Jevon G., and Mock T. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations?. Pediatrics 115 (2005) 1341-1346
131. Murdock A., and Johnston S. Diagnostic criteria for coeliac disease: Time for change?. Eur J Gastroenterol Hepatol 17 (2005) 41-43
132. Collin P., Maki M., Keyrilainen O., Hallstrom O., Reunala T., and Pasternack A. Selective IgA deficiency and coeliac disease. Scand J Gastroenterol 27 (1992) 367-371
133. Cataldo F., Marino V., Bottaro G., Greco P., and Ventura A. Celiac disease and selective immunoglobulin A deficiency. J Pediatr 13 (1997) 306-308
134. Cataldo F., Marino V., Ventura A., Bottaro G., and Corazza G. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: An Italian multicentre study. Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP) and "Club del Tenue" Working Groups on Coeliac Disease. Gut 42 (1998) 362-365
135. Heneghan M., Stevens F., Cryan E., Warner R., and McCarthy C. Celiac sprue and immunodeficiency states: A 25-year review. J Clin Gastroenterol 25 (1997) 421-425
136. Kozlowska H., Rowinski J., Bem W., and Kwarecki K. Fibrous connective tissue of rat binds anti-immunoglobulin antibodies. Folia Histochem Cytobiol 35 (1997) 123-124
137. Kumar V., Jarzabek-Chorzelska M., Sulej J., Karnewska K., Farrell T., and Jablonska S. Celiac disease and immunoglobulin a deficiency: How effective are the serological methods of diagnosis?. Clin Diagn Lab Immunol 9 (2002) 1295-1300
138. Korponay-Szabo I., Dahlbom I., Laurila K., Koskinen S., Woolley N., Partanen J., et al. Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency. Gut 52 (2003) 1567-1571
139. Lenhardt A., Plebani A., Marchetti F., Gerarduzzi T., Not T., Meini A., et al. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of coeliac disease in patients with selective immunoglobulin A deficiency. Dig Liver Dis 36 (2004) 730-734
140. Dahlbom I., Olsson M., Forooz N., Sjoholm A., Truedsson L., and Hansson T. Immunoglobulin G (IgG) anti-tissue transglutaminase antibodies used as markers for IgA-deficient celiac disease patients. Clin Diagn Lab Immunol 12 (2005) 254-258
141. Lo Iacono O., Petta S., Venezia G., Di Marco V., Tarantino G., Barbaria F., et al. Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: Is it always coeliac disease?. Am J Gastroenterol 100 (2005) 2472-2477
142. Vecchi M., Folli C., Donato M., Formenti S., Arosio E., and de Franchis R. High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source. Scand J Gastroenterol 38 (2003) 50-54
143. Villalta D., Crovatto M., Stella S., Tonutti E., Tozzoli R., and Bizzaro N. False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and method-dependent. Clin Chim Acta 356 (2005) 102-109
144. Aldersley M., and Howdle P. Intestinal permeability and liver disease. Eur J Gastroenterol Hepatol 11 (1999) 401-403
145. Ersoz G., Aydin A., Erdem S., Yuksel D., Akarca U., and Kumanlioglu K. Intestinal permeability in liver cirrhosis. Eur J Gastroenterol Hepatol 11 (1999) 409-412
146. Bizzaro N., Villalta D., Tonutti E., Doria A., Tampoia M., Bassetti D., et al. IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Dig Dis Sci 48 (2003) 2360-2365
147. Germenis A., Yiannaki E., Zachou K., Roka V., Barbanis S., Liaskos C., et al. Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. Clin Diagn Lab Immunol 12 (2005) 941-948
148. Korponay-Szabo I., Raivio T., Laurila K., Opre J., Kiraly R., Kovacs J., et al. Coeliac disease case finding and diet monitoring by point-of-care testing. Aliment Pharmacol Ther 22 (2005) 729-737
149. Bürgin-Wolff A., Gaze H., Hadziselimovic F., Huber H., Lentze M., Nussle D., et al. Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child 66 (1991) 941-947
150. Ghedira I., Sghiri R., Ayadi A., Sfar M., Harbi A., Essoussi A., et al. Anti-endomysium, anti-reticulin and anti-gliadin antibodies, value in the diagnosis of celiac disease in the child. Pathol Biol (Paris) 49 (2001) 47-52
151. Simell S., Kupila A., Hoppu S., Hekkala A., Simell T., Stahlberg M., et al. Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility. Scand J Gastroenterol 40 (2005) 1182-1191
152. Lindqvist U., Rudsander A., Bostrom A., Nilsson B., and Michaelsson G. IgA antibodies to gliadin and coeliac disease in psoriatic arthritis. Rheumatology (Oxford) 41 (2002) 31-37
153. Michaelsson G., Ahs S., Hammarstrom I., Lundin I., and Hagforsen E. Gluten-free diet in psoriasis patients with antibodies to gliadin results in decreased expression of tissue transglutaminase and fewer Ki67+ cells in the dermis. Acta Derm Venereol 83 (2003) 425-429
154. Devery J., La Brooy J., Krillis S., Davidson G., and Skerritt J. Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients. Clin Exp Immunol 76 (1989) 384-390
155. ten Dam M., Van De Wal Y., Mearin M., Kooy Y., Pena S., Drijfhout J., et al. Anti-alpha-gliadin antibodies (AGA) in the serum of coeliac children and controls recognize an identical collection of linear epitopes of alpha-gliadin. Clin Exp Immunol 114 (1998) 189-195
156. Lähdeaho M., Vainio E., Lehtinen M., Parkkonen P., Partanen J., Koskimies S., et al. Activation of celiac disease immune system by specific α-gliadin peptides. Cereal Chem 72 (1995) 475-479
157. Krupickova S., Tuckova L., Flegelova Z., Michalak M., Walters J., Whelan A., et al. Identification of common epitopes on gliadin, enterocytes, and calreticulin recognised by antigliadin antibodies of patients with coeliac disease. Gut 44 (1999) 168-173
158. Osman A., Gunnel T., Dietl A., Uhlig H., Amin M., Fleckenstein B., et al. B cell epitopes of gliadin. Clin Exp Immunol 121 (2000) 248-254
159. Cwirla S., Peters E., Barrett R., and Dower W. Peptides on phage: A vast library of peptides for identifying ligands. Proc Natl Acad Sci USA 87 (1990) 6378-6382
160. Devlin J., Panganiban L., and Devlin P. Random peptide libraries: A source of specific protein binding molecules. Science 249 (1990) 404-406
161. Smith G., and Scott J. Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol 217 (1993) 228-257
162. Aleanzi M., Demonte A., Esper C., Garcilazo S., and Waggener M. Celiac disease: Antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem 47 (2001) 2023-2028
163. Anderson R., Degano P., Godkin A., Jewell D., and Hill A. In vivo
164. Tanabe S. IgE-binding abilities of pentapeptides, QQPFP and PQQPF, in wheat gliadin. J Nutr Sci Vitaminol (Tokyo) 50 (2004) 367-370
165. Battais F., Mothes T., Moneret-Vautrin D., Pineau F., Kanny G., Popineau Y., et al. Identification of IgE-binding epitopes on gliadins for patients with food allergy to wheat. Allergy 60 (2005) 815-821
166. Seissler J., Wohlrab U., Wuensche C., Scherbaum W., and Boehm B. Autoantibodies from patients with coeliac disease recognize distinct functional domains of the autoantigen tissue transglutaminase. Clin Exp Immunol 125 (2001) 216-221
167. Marzari R., Sblattero D., Florian F., Tongiorgi E., Not T., Tommasini A., et al. Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J Immunol 166 (2001) 4170-4176
168. Sblattero D., Florian F., Azzoni E., Zyla T., Park M., Baldas V., et al. The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments. Eur J Biochem 269 (2002) 5175-5181
169. Nakachi K., Powell M., Swift G., Amoroso M., Ananieva-Jordanova R., Arnold C., et al. Epitopes recognised by tissue transglutaminase antibodies in coeliac disease. J Autoimmun 22 (2004) 53-63
170. Okita T., Cheesbrough V., and Reeves C. Evolution and heterogeneity of the alpha-/beta-type and gamma-type gliadin DNA sequences. J Biol Chem 260 (1985) 8203-8213
171. Scheets K., and Hedgcoth C. Nucleotide sequence of a gamma gliadin gene. comparisons with other gamma gliadin sequences show the structure of gamma gliadin genes and the general primary structure of gamma gliadins. Plant Sci 57 (1988) 141-150
172. Hull G., Halford N., Kreis M., and Shewry P. Isolation and characterisation of genes encoding rye prolamins containing a highly repetitive sequence motif. Plant Mol Biol 17 (1991) 1111-1115
173. INOVA Diagnostics Home Page. http://www.inovadx.com/Posters/GLIADIN%20PEPTIDE%20POSTER%202005.pdf (Accessed February 2006)
174. Prince H. Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides. Clin Vaccine Immunol 13 (2006) 150-151
175. Sugai E., Vazquez H., Nachman F., Moreno M., Mazure R., Smecuol E., et al. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease. Clin Gastroenterol Hepatol 4 (2006) 1112-1117
176. Prause C., Fredenhagen G., Uhlig H., Richter T., Henker J., Zimmer K., et al. Deamidated gliadin peptide antibody ELISA. In: Stern M. (Ed). Proceedings of the 21st Meeting of the Working Group on Prolamin Analysis and Toxicity (2006) Trieste 2006, Verlag Wissenschaftliche Scripten, Zwickau 2007 (in press)
177. Lock R., Stevens S., Pitcher M., and Unsworth D. Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease?. Eur J Gastroenterol Hepatol 16 (2004) 467-470
178. Vader L., de Ru A., van der Wal Y., Kooy Y., Benckhuijsen W., Mearin M., et al. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med 195 (2002) 643-649
179. Fleckenstein B., Molberg O., Qiao S., Schmid D., von der Mulbe F., Elgstoen K., et al. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. J Biol Chem 277 (2002) 34109-34116
180. Mazzeo M., De Giulio B., Senger S., Rossi M., Malorni A., and Siciliano R. Identification of transglutaminase-mediated deamidation sites in a recombinant alpha-gliadin by advanced mass-spectrometric methodologies. Protein Sci 12 (2003) 2434-2442
181. Mamone G., Ferranti P., Melck D., Tafuro F., Longobardo L., Chianese L., et al. Susceptibility to transglutaminase of gliadin peptides predicted by a mass spectrometry-based assay. FEBS Lett 562 (2004) 177-182
182. Sugimura Y., Hosono M., Wada F., Yoshimura T., Maki M., and Hitomi K. Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: Identification of peptide substrates for TGase 2 and Factor XIIIA. J Biol Chem 281 (2006) 17699-17706 Epub 2007 April 24
183. Otten A., Tschiedel S., Rothemund S., and Mothes T. Substrate specificity of tissue transglutaminase. In: McMillan S., Watson P., Feighery C., and O'Farrelly C. (Eds). Proceedings of the 11th International Symposium on Coeliac Disease (2007) (in press)
184. Arentz-Hansen H., McAdam S., Molberg O., Fleckenstein B., Lundin K., Jorgensen T., et al. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 123 (2002) 803-809
185. Bateman E., Ferry B., Hall A., Misbah S., Anderson R., and Kelleher P. IgA antibodies of coeliac disease patients recognise a dominant T cell epitope of A-gliadin. Gut 53 (2004) 1274-1278
186. U.S. National Center for Biotechnology Information,. http://www.ncbi.nlm.nih.gov/BLAST/ (Accessed March 2006)
187. Stepniak D., Vader L., Kooy Y., van Veelen P., Moustakas A., Papandreou N., et al. T-cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1. Immunogenetics 57 (2005) 8-15
188. Koning F. Celiac disease: Caught between a rock and a hard place. Gastroenterology 129 (2005) 1294-1301
189. Green P., and Jabri B. Celiac disease. Annu Rev Med 57 (2006) 207-221
190. Halttunen T., and Maki M. Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology 116 (1999) 566-572
191. Koning F., Gilissen L., and Wijmenga C. Gluten: A two-edged sword. Immunopathogenesis of celiac disease. Springer Semin Immunopathol 27 (2005) 217-232
192. Qiao S., Bergseng E., Molberg O., Jung G., Fleckenstein B., and Sollid L. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: Importance of proline spacing and glutamine deamidation. J Immunol 175 (2005) 254-261